Rapid identification of bacteria is essential to prevent the spread of infectious disease, help combat antimicrobial resistance, and improve patient outcomes. Raman optical spectroscopy promises to combine bacterial detection, identification, and antibiotic susceptibility testing in a single step.
However, achieving clinically relevant speeds and accuracies remains challenging due to the weak Raman signal from bacterial cellsand the large number of bacterial species and phenotypes. By amassing the largest known dataset of bacterial Raman spectra, we are able to apply state-of-theart deep learning approaches to identify 30 of the most common bacterial pathogens from noisy Raman spectra, achieving antibiotic treatment identification accuracies of 99.0±0.1%. This novel approach distinguishes between methicillin-resistant and -susceptible isolates of Staphylococcus aureus (MRSA and MSSA) as well as a pair of isogenic MRSA and MSSA that are genetically identical apart from deletion of the mecA resistance gene, indicating the potential for culturefree detection of antibiotic resistance. Results from initial clinical validation are promising: using just 10 bacterial spectra from each of 25 isolates, we achieve 99.0±1.9% species identification accuracy. Our combined Raman-deep learning system represents an important proof-of-concept for rapid, culture-free identification of bacterial isolates and antibiotic resistance and could be readily extended for diagnostics on blood, urine, and sputum.
Bacterial infections are a leading cause of death in both developed and developing nations, taking more than 6.7 million lives each year 1, 2 . These infections are also costly to treat, accounting for 8.7%
of annual healthcare spending, or $33 billion, in the United States alone 3 . Current diagnostic methods require sample culturing to detect and identify the bacteria and its antibiotic susceptibility, a slow process that can take days even in state-of-the-art labs 4, 5 . Broad spectrum antibiotics are often prescribed while waiting for culture results 6 , and according to the Centers for Disease Control and Prevention, over 30% of patients are treated unnecessarily 7 . New methods for rapid, culture-free diagnosis of bacterial infections are needed to enable earlier prescription of targeted antibiotics and help mitigate antimicrobial resistance.
Raman spectroscopy has the potential to identify the species and antibiotic resistance of bacteria, and when combined with confocal spectroscopy, can interrogate individual bacterial cells (Figure 1a , b). Different bacterial phenotypes are characterized by unique molecular compositions, leading to subtle differences in their corresponding Raman spectra. However, because Raman scattering efficiency is low (∼ 10 −8 scattering probability 8 ), these subtle spectral differences are easily masked by background noise.
High signal-to-noise ratios (SNRs) are thus needed to reach high identification accuracies 9 , typically requiring long measurement times that prohibit high-throughput single-cell techniques. Additionally, the large number of clinically relevant species, strains, and antibiotic resistance patterns require comprehensive datasets that are not gathered in studies that focus on differentiating between species 10, 11 , isolates (typically referred to as strains in the literature) 12, 13 , or antibiotic susceptibilities [14] [15] [16] [17] [18] [19] .
Results

Deep learning for bacterial classification from Raman spectra
To address this challenge, we train a convolutional neural network (CNN) to classify noisy bacterial spectra by isolate, empiric treatment, and antibiotic resistance. As illustrated in Figure 1 , we measure Raman spectra using short measurement times on dried monolayer samples, ensuring that the majority of individual spectra are taken over single cells and preparation conditions are consistent between samples (See Methods). We construct reference datasets of 60,000 spectra from 30 bacterial and yeast isolates for 3 measurement times -these 30 isolate classes cover over 94% of all bacterial infections treated at Stanford Hospital in the years 2016-17 and are representative of the majority of infections in intensive care units worldwide 20 . We further augment our reference dataset with 12,000 spectra from clinical patient isolates, including MRSA and MSSA isolates (see Methods for full dataset information). Previously, the lack of large datasets prohibited the use of CNNs due to the high number of spectra per bacterial class needed for training.
In recent years, CNNs have been applied with tremendous success to a broad range of computer vision problems [21] [22] [23] [24] [25] [26] [27] . However, while classical machine learning techniques have been applied to spectral data 11, 12, 14, 28, 29 , relatively little work has been done in adapting deep learning models to spectral data [30] [31] [32] .
Our CNN architecture consists of 25 1D convolutional layers and residual connections 33 -instead of two-dimensional images, it takes one-dimensional spectra as input. Unlike previous work, we do not use pooling layers and instead use strided convolutions with the goal of preserving the exact locations of spectral peaks 34 . Empirically, we find that this strategy improves model performance. This is the first work to adapt state-of-the-art CNN techniques from image classification to spectral data (see Methods for further detail).
We train the neural network on a 30-class isolate identification task, where the CNN outputs a probability distribution across the 30 reference isolates and the maximum is taken as the predicted class.
The model is evaluated using a 5-fold cross validation procedure, where 1600 of the 2000 spectra per class are used for training and the remaining 400 are used for evaluating the test accuracy.
A performance breakdown for individual classes is displayed in the confusion matrix in Figure   2a . Here, we show data for 1 s measurement times, corresponding to a SNR of 4.1 -roughly an order of magnitude lower than typical reported bacterial spectra [10] [11] [12] ; classification accuracies increase with SNR, as shown in Supplementary Figure 1 . On the 30-class task, the average isolate-level accuracy is 93.8 ± 0.1%. Gram-negative bacteria are only misclassified as other Gram-negative bacteria; the same is generally true for Gram-positive bacteria, where additionally, the majority of misclassifications occur within the same genus. In comparison, our implementations of the more common classification techniques of logistic regression and support vector machine (SVM) achieve average accuracies of 89.3±
0.2% and 88.7 ± 0.2%, respectively, on our reference dataset.
Identification of empiric treatments
Species-level classification accuracy is the standard metric for bacterial identification, but in practice, the priority for physicians is choosing the correct antibiotic to treat a patient. Common antibiotics often have activity against multiple species, so the 30 isolates can be arranged into groupings based on the recommended empiric treatment if the bacterial species is known. Classification accuracies can thus be condensed into a new confusion matrix grouped by empiric antibiotic treatment (Figure 2b) , where the average accuracy of our method is 99.0±0.1%.
Detection of antibiotic resistance
As a step toward a culture-free antibiotic susceptibility test using Raman spectroscopy, we train a binary CNN classifier to differentiate between methicillin-resistant and -susceptible isolates of S. aureus. This model achieves 95.4±0.5% identification accuracy. Because the consequences for misdiagnosing MRSA as MSSA are often more severe than the reverse misdiagnosis, the binary decision can be tuned for higher sensitivity (low false negative rate), as shown in the receiver operating characteristic (ROC) curve in Figure 2c (dotted line denotes performance of random guessing). The area under the curve (AUC) is 99.1%, meaning that a randomly selected positive example (i.e., Raman sample from patient with MRSA) will be predicted to be more likely to be MRSA than a randomly selected negative example (i.e., sample from patient with MSSA) with probability 0.991.
To test whether our model can detect a specific difference in antibiotic resistance in addition to differences between isolates, we perform binary classification between MRSA 1 and its isogenic variant where the methicillin resistance gene (mecA) is removed 35 ( Figure 3a ). The expression of mecA results in replacement of Penicillin Binding Proteins (PBPs) with PBP2a, which has a low binding affinity for methicillin 36 . The CNN's ability to differentiate the pair with 78.5±0.6% accuracy (Figure 3b) demonstrates sensitivity to a single genetic difference in antibiotic resistance, with all other factors held constant. The ROC curve for the isogenic binary classification has an AUC of 86.1±0.6% (Figure 3c ). Figure 3) . We augment our reference dataset with this clinical dataset comprised of 400 spectra per clinical isolate. To account for changes in the relative prevalence of species and antibiotic resistances over time, the model may be fine-tuned on a small dataset that is representative of current patient populations. We use a leave-one-patient-out crossvalidation (LOOCV) strategy for fine-tuning, where we assign 1 patient in each class to the test set (5 patients total) and use the other 4 for fine-tuning (20 patients total), fine-tuning on 10 randomly sampled spectra per patient isolate -we repeat this 5 times, so all 25 patient isolates appear in the held-out test set once. We then use 10 randomly sampled spectra from each patient isolate in the test set to reach an infection identification for that patient isolate. The sampling procedure for identification is repeated for 10,000 trials, and we report the average accuracy and standard deviation, and display a trial representing the modal result in Figure 4a (full experiment details can be seen in Supplementary Note 1). A CNN pretrained on the reference dataset serves both as initialization for the fine-tuned model and as a baseline, achieving 89.0±3.6% species identification accuracy, a statistically significant improvement over logistic regression and support vector machine baselines (see Methods for details). When the CNN is fine-tuned on clinical data and then evaluated on the held-out patients, the identification accuracy is improved to 99.0±1.9% (Supplementary Figure 4) . Samples for the clinical tests were prepared separately for each patient, so we conclude that the measured performance is not due to batch effects from sample preparation or measurement conditions.
Extension to clinical patient isolates
Because patient samples may contain very low numbers of bacterial cells without culturing (e.g. 1 CFU/mL or fewer in blood 38 ), only a few individual bacterial spectra per patient may be available to make a diagnosis. As seen in Figure 4c , just 10 cellular spectra are enough to reach high identification accuracy.
The rate of correct identification using 10 spectra is 99.0%, within 1% of the performance with 400 spectra (100.0%). While acquiring spectra from 400 individual bacterial cells would likely necessitate culturing, we achieve high accuracy on spectra from 10 individual bacterial cells, demonstrating the potential of our combined Raman-CNN system to diagnose infections using noisy spectra collected from uncultured samples.
Finally, as a step toward antibiotic susceptibility testing on clinical isolates, we collect Raman spectra on 5 additional clinical MRSA isolates and test the binary MRSA/MSSA classifier that is pre-trained on the reference MRSA and MSSA isolates. Using the same LOOCV process, we fine-tune the binary classifier on the clinical spectra. A representative result is shown in Figure 4b , where misclassifications of MSSA as MRSA are labeled as "suboptimal", indicating that Vancomycin (prescribed for MRSA)
is also effective on MSSA but is not considered optimal treatment and may introduce adverse patient effects. On average, the pre-trained binary classifier achieves 61.7±7.3% accuracy and the fine-tuned binary classifier achieves 65.4±6.3% accuracy (Supplementary Figure 4) .
Discussion
This work constitutes the first application of state-of-the-art deep learning techniques to noisy Raman spectra to identify clinically relevant bacteria and their empiric treatment. We have collected the largest known dataset of bacterial Raman spectra, both in terms of spectra per isolate and total number of isolates -the size of this dataset enables deep learning approaches. A CNN model pre-trained on this dataset can easily be extended to new clinical settings through fine-tuning on a small number of clinical isolates, as we have shown on our clinical dataset. We envision that fine-tuning processes such as the one demonstrated here could be important components for continuously evaluating and improving deployed models. Our model, applied here to the identification of clinically relevant bacteria, can be applied with minimal modification to other identification problems such as materials identification, or other spectroscopic techniques such as nuclear magnetic resonance, infrared, or mass spectrometry.
This study uses measurement times of 1 s, corresponding to SNRs that are an order of magnitude lower than typical reported bacterial spectra -while still achieving comparable or improved identification accuracy on more isolate classes than typical Raman bacterial identification studies. A common strategy for reducing measurement times is surface-enhanced Raman scattering (SERS) using plasmonic structures, which can increase the signal strength by several orders of magnitude 11, 39, 40 . SERS spectra can be highly variable and difficult to reproduce, particularly on cell samples 8, 41 , making it difficult to develop a reliable diagnostic method based on SERS. However, with a dataset capturing the breadth of variation in SERS spectra, a CNN could enable a platform that processes blood, sputum, or urine samples in a few hours. [45] [46] [47] [48] and fluorescence or magnetic tagging 49 , Raman spectroscopy has the unique potential to be a technique for identifying phenotypes that does not require specially designed labels, allowing for easy generalizability to new strains.
To achieve treatment recommendations as fine-grained as those from culture-based methods, larger datasets covering greater diversity in bacterial susceptibility profiles, cell states, and growth media and conditions would be needed. Though collecting such datasets is beyond an academic scope, requiring highly automated sample preparation and data acquisition processes, there is promise for clinical translation. Similarly, studies applying the Raman-CNN system to identify pathogens in relevant biofluids such as whole blood, sputum, and urine are a promising future direction to demonstrate the validity of the method as a diagnostic tool. When combined with such an automated system, the Raman-CNN platform presented here could rapidly scan and identify every cell in a patient sample and recommended an antibiotic treatment in one step, without needing to wait for a culture step. Such a technique would allow for accurate and targeted treatment of bacterial infections within hours, reducing healthcare costs and antibiotics misuse, and limiting antimicrobial resistance, and improving patient outcomes. factors held constant can be tested using an isogenic pair of S. aureus, meaning that the two are genetically identical aside from the deletion of the mecA gene which confers methicillin resistance. The expression of mecA results in replacement of Penicillin Binding Proteins (PBPs) with PBP2a, which has a low binding affinity for methicillin. b) A binary classifier is trained to distinguish between these two bacteria, achieving 78.5±0.6% accuracy. c) The ROC shows sensitivities and specificities significantly higher than random classification, with an AUC of 86.1%. that improves to 65.4±6.3% after fine-tuning. c) Dependence of average diagnosis rates for the finetuned model on the number of spectra used per patient. With just 10 spectra, the performance of the model reaches 99% -within 1% difference of the performance with 400 spectra (100%). Error bars are calculated as the standard deviation across 10,000 trials of random selections of n spectra, where n is the number of spectra used per patient.
Methods
Dataset
The reference dataset consists of 30 bacterial and yeast isolates, including multiple isolates of Gramnegative and Gram-positive bacteria, as well as Candida species. We also include an isogenic pair of S. aureus from the same strain, in which one variant contains the mecA resistance gene for methicillin (MRSA) and the other does not (MSSA) 35 (see Supplementary Table 1 for full isolate information). The clinical dataset consists of 30 patient isolates distributed across 5 species. The total dataset consists of 2000 spectra each for the 30 reference isolates plus isogenic MSSA at 3 measurement times, and 400 spectra for each clinical isolate at 1 measurement time.
Dataset variance
For our datasets, we observe that intra-sample variance is high, as demonstrated by the pairwise spectral difference analysis summarized in Fig. 2 . For 19 out of 30 isolates, spectra from at least one other isolate are more similar on average than spectra from the same isolate, on average. For example, when we rank isolates in order of similarity to E. faecalis 2 (Fig. 2c) , there are 8 other isolates where the average difference between a spectrum from E. faecalis 2 and a spectrum from the other isolate is smaller than the average difference between two spectra from E. faecalis 2. When intra-sample variance is high, a large number of spectra per sample may help to better represent the full data distribution and lead to higher predictive performance.
Sample preparation
Bacterial isolates were cultured on blood agar plates each day before measurement. Plates were sealed with Parafilm and stored at 4
• C for 20 minutes to 12 hours before sample preparation. Storage times varied to allow for multiple measurement times per day; however all other sample preparation conditions were kept consistent between samples. Differences in storage time were not found to result in spectral changes greater than spectral changes due to strain or isogenic differences. All clinical isolates were prepared in separate samples with consistent sample preparation conditions. Because test clinical samples were prepared separately from samples used for training, we conclude that classifications are not due to batch effects such as differences in sample preparation. We prepared samples for measurement by suspending 0.6 mg of biomass from a single colony in 10 µL of sterile water (0.4 mg in 5 µL water for
Gram-positive species) and drying 3 µL of the suspension on a gold-coated silica substrate (Figure 1a and b). Substrates were prepared by electron beam evaporation of 200 nm of gold onto microscope slides that were pre-cleaned using base piranha. Samples were allowed to dry for 1 hour before measurement.
Raman measurements
We measured Raman spectra across monolayer regions of the dried samples ( Figure 1a ) using the mapping mode of a Horiba LabRAM HR Evolution Raman microscope. 633 nm illumination at 13.17 mW was used with a 300 l/mm grating to generate spectra with 1.2 cm −1 dispersion to maximize signal strength while minimizing background signal from autofluorescence. Wavenumber calibration was performed using a silicon sample. The 100X 0.9 NA objective lens (Olympus MPLAN) generates a diffraction-limited spot size, ∼1 µm in diameter. A 45x45 discrete spot map is taken with 3 µm spacing between spots to avoid overlap between spectra. The spectra are individually background corrected using a polynomial fit of order 5 using the subbackmod Matlab function available in the Biodata toolbox (see Supplementary Figure 1 for examples of raw and corrected spectra). The majority of spectra are measured on true monolayers and arise from1 cell due to the diffraction-limited laser spot size, which is roughly the size of a bacteria cell. However, a small number of spectra may be taken over aggregates or multilayer regions. We exclude the spectra that are most likely to be non-monolayer measurements by ranking the spectra by signal intensity and discarding the 25 spectra with highest intensity, which includes all spectra with intensities greater than two standard deviations from the mean. We measured both monolayers and single cells, and found that monolayer measurements have SNRs of 2.5±0.7, similar to single-cell measurements (2.4±0.6), while allowing for the semi-automated generation of a large training dataset. The spectral range between 381.98 and 1792.4 cm −1 was used, and spectra were individually normalized to run from a minimum intensity of 0 and maximum intensity of 1 within this spectral range.
SNR values are calculated by dividing the total intensity range by the intensity range over a 20-pixel wide window in a region where there is no Raman signal.
CNN architecture & training details
The CNN architecture is adapted from the Resnet architecture 33 that has been widely successful across a range of computer vision tasks. It consists of an initial convolution layer followed by 6 residual layers and a final fully connected classification layer -a block diagram can be seen in Figure 1 . The residual layers contain shortcut connections between the input and output of each residual block, allowing for better gradient propagation and stable training (refer to 33 for details). Each residual layer contains 4 convolutional layers, so the total depth of the network is 26 layers. The initial convolution layer has 64 convolutional filters, while each of the hidden layers has 100 filters. These architecture hyperparameters were selected via grid search using one training and validation split on the isolate classification task. We also experimented with simple MLP and CNN architectures but found that the Resnet-based architecture performed best.
We first train the network on the 30-isolate classification task, where the output of the CNN is a vector of probabilities across the 30 classes and the maximum probability is taken as the predicted class. While a high number of samples is good for ensuring dataset variation, deep learning approaches can still benefit from having a high number of examples per sample. When intra-sample variance is high, as we observe for our datasets, a large number of spectra per sample may better represent the full distribution and lead to higher predictive performance.
For the clinical isolates, we start by pre-training a CNN on the empiric treatment labels for the 30 reference isolates. We then use the following leave-one-patient-out cross-validation (LOOCV) strategy to fine-tune the parameters of the CNN. There are a total of 25 patient isolates across 5 species. In each of the 5 folds, we assign 1 patient in each species to the test set, 1 patient in each species to the validation set, and the remaining 3 patients in each species to the training (i.e., fine-tuning) set. We then use the clinical training set (consisting of isolates from 15 patients) to fine-tune the CNN parameters, and use accuracy on the validation set (5 patient isolates) to do model selection. The test accuracy for each fold is evaluated on the test set (5 patient isolates) using the method described below.
Clinical identification data analysis
To reach an identification for patient isolates, 400 spectra are measured across a sample from each patient isolate. 10 of these spectra are chosen at random to be classified. The most common class out of the 10 spectral classifications is then chosen as the identification for each patient isolate, with ties broken randomly. All error values reported for tests on the clinical dataset are standard deviations across 10,000 trials of random selections of 10 spectra.
Baselines
In all experiments where logistic regression (LR) and support vector machine (SVM) baselines were used, we first used PCA to reduce the input dimension from 1000 to 20 -this hyperparameter was determined by plotting test accuracies for different settings on one training and validation split for the 30 isolate task and picking a value near where the test accuracy saturated. Using only the first 20 principal components not only decreases computation costs, but also increases accuracy by reducing the amount of noise in the data. For each fold of the cross validation procedure, we use grid search to choose the regularization hyperparameter for each model achieving the best validation accuracy and report the corresponding test accuracy.
Two-sample test of sample means
We use the Welch's two-sample t-test to test whether the differences in mean clinical accuracy for the CNN and the SVM and LR baselines were statistically significant. Welch's t-test is a variation of the Student's t-test that is used when the two samples may have unequal variances. In each case, we start by computing the pooled standard deviation as
We then compute the standard error of the difference between the means as
Finally, we can compute the test statistic as
and then compute the p-value using the corresponding Student's t-distribution. For our computations, n CNN = n LR = n SVM = 10000, µ CNN = 89.0, µ LR = 81.8, µ SVM = 82.9, σ CNN = 3.6, σ LR = 6.0, and σ SVM = 5.9. In comparing the CNN with LR, we computed a t-statistic of 102.9 and in comparing the CNN with SVM, we computed a t-statistic of 88.3. In both cases, we reject the null hypothesis that the means are equal at the 1e-6 p-level.
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Source code, trained models, and examples can be accessed at https://github.com/nealjean/ raman-demo/ Inter-isolate vs intra-isolate pairwise spectral differences. Average differences are calculated as the average L2 distance between pairs of spectra over 4 million (2000 x 2000) possible pairs. a) Intra-isolate distances (along the diagonal) are computed as the difference between two spectra from the same isolate, while inter-isolate distances (off-diagonals) are computed as the difference between one spectrum from the row isolate and one spectrum from the column isolate. For each row, red marks indicate isolates for which inter-isolate differences are smaller than the average intra-isolate difference for the isolate in that row. Blue marks simply indicate the location of the diagonal for reference. For example, in the second row, the average distance between an MSSA 1 spectrum and an MRSA 1 spectrum is smaller than the average distance between two MRSA 1 spectra in other words, MSSA 1 and MRSA 1 spectra are more similar (on average) than MRSA 1 spectra are to themselves (on average). b) For each isolate, we summarize the total number of more similar isolates. For 19 out of 30 isolates, spectra from at least one other isolate are more similar than spectra from the same isolate. c) Example sort by similarity for E. faecalis 2, demonstrating that spectra from 8 isolates are more similar on average to E. faecalis 2 than different spectra from E. faecalis itself, on average. Pre-trained on cell-line spectra Fine-tuned on clincial spectra Assign 1 patient to test set and 4 patients to training set for each species
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